Our COVID-19 tracker contains the most recent information on Maine cases by county. Click here for the latest coronavirus news, which the BDN has made free for the public. You can support this mission by purchasing a digital subscription. WASHINGTON — Facing public criticism, the maker of a promising coronavirus drug said Wednesday it will waive a special regulatory designation that could have allowed it to block competition and boost profits for its treatment. Gilead Sciences said it will ask U.S.